Maximizing revenue under the BCBSM incentive program
Did you know? Blue Cross Blue Shield of MI withholds 5 percent of all commercial payments. That means even if you’re earning 100% of the standard fee schedule, you’re still losing 5 percent! Pathology value-based reimbursement For years, BCBSM has...
Analyzing the overhauled 14-day molecular billing rule
Under the old CMS 14-Day Rule, reference and independent laboratories were barred from billing Medicare directly for molecular pathology tests ordered less than 14 days after an outpatient was discharged from the hospital. Besides the obvious administrative challenges...